Public Acceptance and Willingness-to-Pay for a Future Dengue Vaccine: A Community-Based Survey in Bandung, Indonesia by Hadisoemarto, Panji Fortuna & Castro, Marcia C.
 Public Acceptance and Willingness-to-Pay for a Future Dengue
Vaccine: A Community-Based Survey in Bandung, Indonesia
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Hadisoemarto, Panji Fortuna, and Marcia C. Castro. 2013. “Public
Acceptance and Willingness-to-Pay for a Future Dengue Vaccine:
A Community-Based Survey in Bandung, Indonesia.” PLoS
Neglected Tropical Diseases 7 (9): e2427.
doi:10.1371/journal.pntd.0002427.
http://dx.doi.org/10.1371/journal.pntd.0002427.
Published Version doi:10.1371/journal.pntd.0002427
Accessed February 19, 2015 2:30:49 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11877027
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Public Acceptance and Willingness-to-Pay for a Future
Dengue Vaccine: A Community-Based Survey in
Bandung, Indonesia
Panji Fortuna Hadisoemarto1,2*, Marcia C. Castro1
1Department of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, United States of America, 2Department of Public Health, Faculty
of Medicine, Padjadjaran University, Bandung, West Java, Indonesia
Abstract
Background: All four serotypes of dengue virus are endemic in Indonesia, where the population at risk for infection exceeds
200 million people. Despite continuous control efforts that were initiated more than four decades ago, Indonesia still suffers
from multi-annual cycles of dengue outbreak and dengue remains as a major public health problem. Dengue vaccines have
been viewed as a promising solution for controlling dengue in Indonesia, but thus far its potential acceptability has not
been assessed.
Methodology/Principal Findings: We conducted a household survey in the city of Bandung, Indonesia by administering a
questionnaire to examine (i) acceptance of a hypothetical pediatric dengue vaccine; (ii) participant’s willingness-to-pay
(WTP) for the vaccine, had it not been provided for free; and (iii) whether people think vector control would be unnecessary
if the vaccine was available. A proportional odds model and an interval regression model were employed to identify
determinants of acceptance and WTP, respectively. We demonstrated that out of 500 heads of household being
interviewed, 94.2% would agree to vaccinate their children with the vaccine. Of all participants, 94.6% were willing to pay
for the vaccine with a median WTP of US$1.94. In addition, 7.2% stated that vector control would not be necessary had there
been a dengue vaccination program.
Conclusions/Significance: Our results suggest that future dengue vaccines can have a very high uptake even when
delivered through the private market. This, however, can be influenced by vaccine characteristics and price. In addition,
reduction in community vector control efforts may be observed following vaccine introduction but its potential impact in
the transmission of dengue and other vector-borne diseases requires further study.
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Introduction
Dengue is endemic in more than 100 countries and places more
than 2.5 billion people at risk [1]. Recent modeling of global
dengue burden estimated a total of 390 million dengue infections
occur annually [2]. This is almost eight times larger than the
World Health Organization (WHO) estimate of 50 million dengue
infections annually, of which resulted in hospitalization of 1.5
million cases of Dengue Hemorrhagic Fever (DHF) and Dengue
Shock Syndrome (DSS) and a case fatality rate of 2.5% [1].
Indonesia is one of the countries where dengue is hyperendemic
and all four serotypes are known to circulate in at least 400 of its
497 districts, with more than 200 million people at risk for dengue
infection [3]. Recent modeling estimated about 30 million dengue
infections occur in Indonesia every year [2].The presence of all
four dengue serotypes possibly contributes to the multi-annual
cycle of dengue outbreaks with inter-epidemics seasonal transmis-
sion [4], with a trend of increasing number of reported DHF cases.
In one of the worst dengue outbreaks that occurred in 2010, more
than 150,000 cases of DHF were reported to the Ministry of
Health of Indonesia, including more than 30,000 hospitalizations
[3].
To control dengue virus transmission, the Indonesian dengue
program has been focusing its efforts in community-based
mosquito breeding place reduction [5]. The program is famous
for the slogan ‘‘3M’’ that stands for covering (Menutup) and
cleaning (Menguras) water containers, and burying (Mengubur)
discarded water containers. However, control of female Aedes
aegypti mosquito has proven difficult due to its adaptability to the
human-made environment, especially in urban settings where
dengue is most prevalent [6].
Vaccines have been proposed as a promising solution to dengue
control [7]. As of today, more than ten dengue vaccine candidates
are in the development pipeline [7], and at least one candidate
tetravalent dengue vaccine is projected to be available in the
market within the next five years [8]. The magnitude of dengue
problems suggests that Indonesia will benefit from a dengue
vaccine, as had been suggested by policy makers in the country
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[9]. Another reason for including a vaccination strategy is the
Expanded Program of Immunization (EPI) that has been running
from 1977 [10]. To deliver routine vaccinations against seven
diseases (polio, measles, diphtheria, tetanus, pertussis, tuberculosis
and hepatitis B), the EPI program is supported by a network of
7,800 community health centers, with more than 250,000
community-organized health posts.
On top of the aforementioned epidemiological and program-
matic facts, public acceptance should be taken into account in the
light of decreasing public trust on vaccination [11]. This is
especially true following the false claim made on the link between
autism and MMR [12]. In addition, anecdotal evidence also shows
concerns over big business involvement, western conspiracy, and
the permissibility to use vaccines according to religious teachings,
all of which can affect the decision to vaccinate in Indonesia, a
predominantly Muslim country (for example, [13]). Nonetheless,
few studies on vaccine acceptance in Indonesia showed more than
90% parental acceptance for HPV and anti-typhoid vaccines
[14,15]. Similar studies for a future dengue vaccine are, however,
still unavailable.
Financing a dengue vaccination program may be a challenge for
a developing country like Indonesia [16]. Thus far, Indonesia self-
finances the EPI program with vaccines produced by a govern-
ment-owned company [10,17]. Fully vaccinating an infant with
EPI vaccines, however, costs less than US$1.00 and the
introduction of new vaccination may increase this cost substan-
tially [18]. Indonesian policy makers suggested that the govern-
ment could finance a dengue vaccination program if the vaccine
price is non-prohibitive, with a maximum recommended price of
$0.50 per dose [9]. Hence, private source financing may be needed
to supplement public financing. For example, a study from the
Philippines suggested a mean willingness-to-pay (WTP) for a
dengue vaccine of $27 [19]. Viability of delivering such vaccine in
the private sector in Indonesia, however, has not been studied.
Arguably, a vaccination program may be followed by a
reduction in mosquito control behaviors. Using analogy from
other diseases, a study by Newman et al. (2009) found that 10% of
high-risk subjects expressed that they would reduce their condom
use had they been vaccinated against HIV, which might lead to an
increase of other adverse outcomes of unprotected sex [20].
Should this happen following a dengue vaccination program,
community-centered mosquito control efforts may be reduced and
may lead to an increase in the transmission of other mosquito-
borne diseases, such as chikungunya, a virus that shares common
vectors with dengue virus [21]. Outbreaks of chikungunya have
been documented in many dengue endemic regions in Indonesia
[22], and at least one study found that chikungunya is also
circulating year round in the city of Bandung [23].
This study contributes to these discussions through a household
interview in the city of Bandung, Indonesia. Bandung (total
population: 2.3 million) is the fourth most densely populated city in
Indonesia with 14,710 people living per square kilometer. Dengue
is known endemic, with transmission pattern similar to that
observed in Indonesia as a whole [24]. The largest dengue
outbreak in Bandung for the past decade occurred in 2009, with a
total of 6,678 DHF cases reported to the Ministry of Health
(incidence rate: 276 DHF cases/100,000 people). In addition,
circulation of all four dengue serotypes in the city has also been
documented [25].
In this study, we assessed the extent to which parents would
vaccinate their children, and their willingness to pay for a dose of
vaccination, in the case that the vaccine was not provided free of
charge by the government. We also assessed eventual changes in
current dengue control behavior had there been a dengue
vaccination program. Potential modifiable determinants were
explored to generate recommendation for policy makers in dengue
endemic areas.
Methods
Ethic Statement
Ethical approval for the study was obtained from the Harvard
School of Public Health (Protocol #19173-101) and Padjadjaran
University Faculty of Medicine. Survey participants signed an
informed-consent form prior to enrollment even though the study
met the criteria for exemption.
Household Survey
The city of Bandung is divided into 30 sub-districts (kecamatan),
which are further divided into 151 villages (kelurahan). Four villages
within two sub-districts were selected in consultation with local
officials from the Ministry of Health on the basis of representa-
tiveness of the target population for a pediatric dengue vaccine in
the city of Bandung, accessibility, cooperativeness of local staff and
community members, and availability of community health
workers. Within a village, households were systematically sampled,
starting from a random house and sampling every fifth house until
the quota for each village was achieved. The head of household or
his spouse was then invited to participate in the study. Between
May and July of 2010, we enrolled a total of 500 participants
within two sub-districts, Ujung Berung and Antapani. In sub-
district Ujung Berung, we enrolled 123 (24.6%) from Pasang-
grahan village and 127 (25.4%) participants from Cigending
village.
In sub-district Antapani, interviewers were not able to reach the
quota of 125 participants in Antapani Kidul village because of
unavailability of community health workers. Hence, the quota for
the sub-district was therefore fulfilled by sampling more house-
holds in the other village within the sub-district, Antapani Tengah.
As the result, Antapani Kidul had only 75 (15%) households
interviewed whereas the number of household sampled in
Antapani Tengah was 175 (35%).
The interview was conducted in Bahasa Indonesia by final year
medical students from Padjadjaran University who were trained
Author Summary
While methods for vector control such as mosquito
breeding source reduction and focal insecticide spraying
that have been practiced to reduce dengue transmission in
Indonesia have had limited success, dengue vaccines are
expected to be an effective control method. However,
even if an efficacious vaccine is developed, public
acceptance and viable financing mechanisms are crucial
for a successful introduction and sustainability of a new
vaccination program. In this paper, we report public
acceptance and willingness-to-pay for a hypothetical
dengue vaccine for children that would be made available
in the future. We found a very high proportion of surveyed
participants, more than ninety-four percent, were willing
to accept and pay for the vaccine. These findings provide a
strong support for a dengue vaccination program. On the
other hand, we also found a small possibility of reduction
in vector control efforts if a dengue vaccination program is
put in place. This could have a potential to increase the
transmission of other vector-borne diseases and should be
taken into account when introducing a dengue vaccina-
tion program.
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for the study. To guide and facilitate access to the community,
local community health workers were recruited. All 500 house-
holds were interviewed over the course of 5 days.
A questionnaire was developed to record participants’ demo-
graphic information and to measure knowledge, attitude and
practice related to dengue, dengue prevention and vaccination in
general, acceptance and willingness to pay for a dengue vaccine
and their opinion on whether vector control would be necessary
had there been a dengue vaccination program. A pilot study
involving 30 participants was conducted prior to the survey in
order to validate the questionnaire.
Socioeconomic Level
An asset index was constructed using Principal Component
Analysis (PCA), as suggested by Filmer and Prittchett (1999) to
categorize participants’ socioeconomic level [26], based on fifteen
indicator variables, namely access to piped-water, ownership of
flushed toilets, radio, landline phone, refrigerators, personal
computers, bicycles, motorcycles, cars, internet connection,
whether or not they own the housing unit, having a separate
room functioning as kitchen and whether the house is built with
non-dirt flooring, roof tiles, and brick walls. The first principal
component of asset ownership across households explained 25% of
the variability. For each household, the asset index was
constructed as the sum of standardized asset scores multiplied by
their respective factor loadings. Finally, quintiles of the asset index
were calculated; households classified in the 1st quintile are the
poorest, while those in the 5th quintile are the least poor.
Primary Outcomes
Primary outcomes of interest in this study were: (i) participants’
acceptance of a future, hypothetical, dengue vaccine; (ii) their
WTP for the vaccine, had it not been provided for free; and (iii)
whether people think vector control would be unnecessary if the
vaccine was available. To elicit acceptance of a future dengue
vaccine, it was hypothesized that the vaccine would be 100% safe
and protective against dengue and provided free by the
government as a single dose injection. Acceptance of vaccine
was measured by asking participants to respond to the question
‘‘would it be likely for you to vaccinate your children?’’ in a 5-
point Likert-like scale ranging from ‘‘very unlikely’’ to ‘‘very
likely’’.
To assess WTP for the hypothetical pediatric dengue vaccine,
participants were given a scenario where a fully protective, single
dose, dengue vaccine was available. To elicit the maximum
amount of money they would be willing to pay for to vaccinate
their children, interviewers went through a list of maximum
amount of money in an ascending manner starting from less than
10,000 Indonesian Rupiah (IDR); 25,000; 50,000; 75,000;
100,000 and more than IDR100,000 (equivalent to US$1.1,
2.75, 5.5, 8.25, 11.00 and more than 11.00, using the July 2010
exchange rate; US dollar will be used from this point forward). All
prices that a participant agreed to pay for was recorded until either
the highest price listed or the amount at which participant was no
longer willing to pay for was reached. Stated maximum WTP was
converted into intervals of bounds of WTP, called from now on as
the true WTP, which lies between the highest price a participant
would be willing to pay and the next, higher, listed maximum
WTP. For example, if a participant agreed to pay a maximum
price of $5.5 but not $8.25, the interval that includes true WTP is
assumed to be between $5.5 and $8.25. Options to vaccinate their
children only when the vaccine was provided free or not to
vaccinate their children at all were also provided.
Lastly, to probe for possible behavior change following a dengue
vaccination campaign, participants were provided with a scenario
where a dengue vaccination campaign using an effective and safe
vaccine had been launched. Their responses were recorded in a 5-
point scale from ‘‘strongly disagree’’ to ‘‘strongly agree’’ to the
statements ‘‘the 3M movement is no longer necessary’’ and ‘‘you
are not going to do any dengue prevention anymore’’.
Knowledge, Attitude and Practice Related to Dengue
Participants were asked about their knowledge about the
symptoms and prevention of dengue, and about dengue virus
transmission. To prevent participants from guessing, interviewers
did not read aloud choices of answers provided in the question-
naire. Answers that were not listed in the questionnaire were
written down and later recoded to match one or more listed
options closest to participants’ answer.
Responses to knowledge questions were scored between 0 and 1.
For questions that had only one possible correct response, a score
of 1 was given for that response and 0 otherwise. On the other
hand, a score of 0.5 was given for knowledge about dengue
symptoms and Aedes breeding places if the participant could
mention between 1 to 3 correct answers (out of 12 listed for each
question) and a score of 1 was given if more than 3 correct
responses were provided. For knowledge of dengue prevention, a
score of 0.5 was given if the participant could mention one method
and a score of 1 was given if more than one method was named.
Participants were given a score of 0.3 for correctly mentioning one
of the three M’s in 3M, a score of 0.7 for 2 correct Ms, and a score
of 1 for correctly mentioning all three components of 3M. A score
of 0 was assigned when the answer was ‘‘don’t know’’ or when the
response was incorrect.
Based on this scoring method, we developed a composite
dengue knowledge index by including items that maximized the
Cronbach’s Alpha value as a measure of internal consistency [27].
The final composite index consisted of eight items (Alpha= 0.71)
with possible values ranging from 0 to 8. For a more meaningful
interpretation in the subsequent analysis, we categorized knowl-
edge scores into tertiles of ‘‘good’’ when the knowledge index
scored greater than 6, ‘‘sufficient’’ (index score 4–5) and ‘‘poor’’
(index score,4).
To measure participants’ attitude towards dengue prevention,
we asked thirteen 5-point Likert-like questions [28]. Response
category scales for statements read by interviewers ranged from
‘‘strongly disagree’’ to ‘‘strongly agree’’ with ‘‘undecided’’ as the
mid-point. In the analysis, some of the item responses were
reverse-coded such that higher score can be assumed to predispose
a better practice of dengue prevention efforts. We then constructed
a composite attitude index in a similar manner to the construction
of knowledge index. A total of five items were used in the final
composite index (Alpha= 0.50) with possible scores ranging from 5
to 25. We further categorized attitude index into tertiles of ‘‘low
support’’ (score,12), ‘‘somewhat supportive’’ (score 12–14), and
‘‘highly supportive’’ (score.14).
Similarly, five 5-point Likert-like questions were asked to
measure participants’ acceptance of vaccination programs. A total
of three items were included in the final composite index
(Alpha= 0.52) with scores ranging from 3 to 15, where a higher
score indicates higher support for vaccination. We categorized the
acceptance of vaccination scores into tertiles of ‘‘low support’’
when index score was 11 or lower, ‘‘somewhat supportive’’
(score = 12), and ‘‘highly supportive’’ (score.12).
Participants were also asked to report their practice of dengue
prevention. Participants were categorized into tertiles of the
number of prevention methods being practiced in the month prior
Dengue Vaccine Acceptance in Bandung, Indonesia
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to the interview, namely ‘‘no effort’’ if they reported no dengue
control activities, while those who reported 1 effort and 2 or more
efforts were categorized as having ‘‘low effort’’ and ‘‘high effort’’,
respectively.
Methodological Approach
In addition to using descriptive statistics of the primary
outcomes and covariates of interest, we employed an ordinal
regression with a proportional odds assumption to test for the
association between dengue vaccine acceptance and several
independent variables. The formal model is given by [29]:
log
Pr(Yƒyi Dx)
Pr(Ywyi Dx)
 
~ai{Xb, i~1, 2, . . . , k{1,
where the left-hand side of the equation is the log odds of being in
the i-th category for a k-category response variable; ai are the
intercept parameters for every category I; and b is a vector of
regression parameters (b1, b2, b3, …, bj) for X, the set of j
explanatory variables in the regression equation.
Because proportional odds ratio model is invariant in magni-
tude when the coding of outcome variable is reversed, response to
outcome variable of interest (dengue vaccine acceptance) was
reverse coded such that eb’s can be interpreted as the odds ratio for
having a higher level of acceptance associated with a one unit
increase in the dependent variable, holding other variables
constant. Variables included as covariates in the model were
age, gender, indicators of educational level, and indicators of
socioeconomic level (see Table 1); personal experience with
dengue, indicators of dengue knowledge level, indicators of
attitude towards dengue prevention, indicators of level of support
for vaccination and indicators of level of dengue prevention effort.
Parameters for the model were estimated using PROC LOGIS-
TIC procedure in SAS 9.30 (SAS Institute, Cary, USA).
To estimate the WTP, we excluded those who would not
vaccinate their children and those who would vaccinate their
children only when the vaccine is provided for free, assuming that
lower bound of WTP cannot be less than zero. We then fit an
interval regression model to the intervals of the true WTP using
PROC LIFEREG procedure in SAS 9.30 [30,31]. The model is
described as:
ln(WTP)~Xbzse,
where ln(WTP) is assumed to lie in the interval between the log
highest price that a participant was willing to pay and the next log
highest price stated in the list, b is a vector of regression
parameters, s denotes the scale parameter for the distribution,
and e is a vector of error terms that are assumed to be normally
distributed. The conditional mean and median of predicted WTP
can be estimated as expXbz
s2=2 and expXb, respectively [30]. To
examine the associations of different variables with the true WTP,
covariates (X) included in the WTP model were the same as those
included in the previous proportional-odds model.
Results
Demographics
More than 80% of participants were female. This may have
resulted from the timing of the interview, mostly conducted in
weekdays and, to the fact that the household head often delegated
participation to his wife. Consequently, most participants reported
having no employment because most of them were stay at home
mothers. The four villages varied in the socioeconomic distribution
of the participants (Table 2). Antapani Kidul and Pasanggrahan
had more participants from lower education and socioeconomic
levels compared to Antapani Tengah and Cigending. However,
between villages comparisons are not of interest to this study, and
therefore these differences should not pose a problem on the
interpretation of subsequent analyses. Although only a few study
participants reported having had prior dengue episode, almost
70% recognized someone who had dengue, reflecting the high
dengue incidence in the area.
Knowledge of Dengue
More than half of the participants (66.8%) knew that dengue
virus is transmitted by mosquitoes. After being informed that
Table 1. Variables used in the regression analyses.
Variable Value
Dependent variables
Vaccine acceptance 1 – Unlikely
2 – Likely
3 – Very likely
Willingness-to-pay .IDR0 – ,10000
.10000–25000
.25000–50000
.50000–75000
.75000–100000
.IDR100000
Independent variables
Dengue experience 0 – No
1 – Yes
Sex 0 – Female
1 – Male
Education level 1 – Junior high and lower
2 – Senior high
3 – College and higher
Socioeconomic level 1 – Poorest quintile
2 – 2nd
3 – 3rd
4 – 4th
5 – Richest quintile
Dengue knowledge 1 – Poor
2 – Sufficient
3 – Good
Dengue attitude 1 – Weakest
2 – Middle
3 – Strongest
Vaccine attitude 1 – Low support
2 – Supportive
3 – Highly supportive
Preventive effort 1 – No effort
2 – Low effort
3 – High effort
Age (mean) Centered at mean age, 42.6 years
doi:10.1371/journal.pntd.0002427.t001
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dengue virus is transmitted by mosquito bites, 57.3% could
mention Aedes as the mosquito responsible for the transmission. On
the other hand, 68.7% correctly recognized the characteristics of
the mosquito responsible for dengue transmission as a black
mosquito with white stripes. Finally, having been told about all of
the information above, 91.9% correctly identified dengue as
predominantly transmitted in daytime.
Fever was the most cited dengue symptom (87.2%) followed by
red spots on the skin (ptechiae) (67.6%) and other signs or
symptoms. Most participants could mention at least one place of
Aedes breeding with standing and clean water being the most
frequently mentioned by 50.4% and 43.4% of participants,
respectively. Components of 3M movement were the most cited
dengue prevention methods, although only 8.2% specifically
mentioned 3M as one of the methods. Outside of 3M, use of
some type of insecticide was also frequently mentioned, as well as
fogging or focal spraying and larviciding. Distribution of correct
responses for questions measuring dengue knowledge is summa-
rized in Table 3.
Attitude on Dengue Prevention
Table 2 summarizes the distribution of responses to the five
items measuring attitude toward dengue prevention. Most
participants considered the city of Bandung as a dengue high-
risk area; although most of them did not think that the condition
particularly applied to their neighborhood. There was a high
agreement on dengue as not being the most important disease in
the city, although we did not attempt any further effort to identify
what disease participants considered as the most important. Most
participants (79.4%) agreed that the government was working hard
to prevent dengue. In contrast, there was an overall lack of
confidence that dengue prevention could be effectively undertaken
by the community or community members.
Dengue Prevention Practice
Participants were asked to report their practice of dengue
prevention in the past week prior to the survey. Themost commonly
practiced dengue prevention methods were those identified as parts
of the 3Mmovement, although not every component were reported
equally often. More than 50% reported that they changed the water
inside containers regularly to prevent dengue. In addition, use of
insecticides in the forms of sprayed liquid insecticide (10.6%),
mosquito coils (5.2%) and insecticide with electric vaporizer (8.0%)
were also prevalent. Prevalence of reported methods of dengue
prevention practice is described in Table 3.
Attitude on Vaccination Practice
Five questions were asked to elicit opinion about vaccination
(Table 4). In general, there was a very positive attitude about
vaccination where the majority of participants agreed that
vaccinations were important for disease prevention and that they
were safe to be used. The most preferred place to obtain child
vaccination was the community integrated health post (27.3%)
followed by midwives and community health centers (25.5% and
19.6%, respectively).
Acceptance of Dengue Vaccination
A total of 94.2% of the participants expressed that they were
likely or very likely to vaccinate their children. Table 5 shows the
proportional odds ordinal regression results with likeliness of
Table 2. Demographic characteristics of participants in each of the villages.
Characteristics Sub-district Antapani Sub-district Ujung Berung
Antapani Kidul (n =75) Antapani Tengah (n =175) Cigending (n =127) Pasanggrahan (n =123)
Sex (%)
Male 9 (12.0) 27 (15.4) 23 (18.1) 18 (14.6)
Female 66 (88.0) 148 (84.6) 104 (81.9) 105 (85.4)
Age 38.0 45.7 43.1 40.7
Education level (%)
Junior high or lower 58 (77.3) 29 (16.6) 59 (46.5) 83 (67.5)
Senior high 12 (16.0) 96 (54.9) 54 (42.5) 29 (23.6)
College or higher 5 (6.7) 50 (28.6) 14 (11.0) 11 (8.9)
Employment (%)
Own a business 21 (28.0) 26 (14.9) 20 (15.8) 13 (10.6)
Employee 4 (5.3) 17 (9.7) 13 (10.2) 22 (17.9)
Free lance 8 (10.7) 4 (2.3) 3 (2.4) 12 (9.8)
Not employed 42 (56.0) 128 (73.1) 91 (71.7) 76 (61.8)
Ever had dengue (%) 5 (6.7) 13 (7.4) 7 (5.5) 11 (8.9)
Knows someone who had dengue (%) 29 (38.7) 142 (81.1) 99 (77.9) 79 (64.2)
Socioeconomic level (%)
Poorest quintile 44 (59.5) 4 (2.3) 16 (12.8) 35 (28.9)
2nd 21 (28.4) 14 (8.2) 26 (20.8) 37 (30.6)
3rd 3 (4.1) 25 (14.6) 45 (36.0) 26 (21.5)
4th 5 (6.8) 52 (30.4) 24 (19.2) 16 (13.2)
Richest quintile 1 (1.4) 76 (44.4) 14 (11.2) 7 (5.8)
doi:10.1371/journal.pntd.0002427.t002
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vaccinating children as the outcome variable. Due to low number of
responses, categories ‘‘very unlikely’’, ‘‘unlikely’’ and ‘‘undecided’’
for vaccine acceptance were collapsed into one single category. A
total of 464 observations were included in the final model.
Our model demonstrated that supportive attitude on vaccina-
tion practice was the factor most strongly associated with stronger
support for dengue vaccination. Compared to participants with
low level of support, those within the ‘‘somewhat supportive’’
group of support for vaccination practice were twice more likely to
have better support for a dengue vaccine (95% CI: 0.94–4.15, p-
value = 0.07) whereas those with a high supportive attitude on
vaccination were five times more likely to have a better support for
dengue vaccination (95% CI: 2.23–11.20, p-value,0.01).
In addition, personal experience with dengue, whether direct
experience from past dengue episode or indirect experience of
knowing someone who had dengue, was also strongly correlated
with support for dengue vaccination. Participants having personal
experience were almost twice more likely to have better
acceptance to a dengue vaccine compared to those who did not
have personal dengue experience (OR: 1.9, 95% CI: 1.18–2.99, p-
value,0.01).
In contrast, individuals who completed a high school education
were less likely to support dengue vaccination compared to those
with lower education (OR: 0.5, 95% CI: 0.27–0.76, p-
value,0.01). This association, however, was not observed among
participants with a college degree or higher. Other covariates were
not found to be strongly associated with acceptance of dengue
vaccine.
When asked to rank the importance of four vaccine character-
istics, more than 50% participants valued full protection against
Table 3. Responses to questions measuring knowledge and dengue prevention practiced in the past month.
Item # Question Correct response (%)*
(n =500)
Knowledge 1 Can you mention symptoms of dengue?** 93.4
2 How is dengue transmitted? 66.9 (n = 498)
3 What mosquito transmits dengue? 57.3 (n = 499)
4 How does Aedes mosquito look like? 68.7 (n = 499)
5 When does Aedes mosquito bite? 91.9 (n = 483)
6 Where does Aedes breed? 91.6
7 How can you prevent dengue?** 80.8
8 What does 3M stand for?** 67.0
Practice 1 Change water in containers 52.6
2 Cover water containers 22.8
3 Bury unused containers 20.4
4 Practice 3 M 11.2
5 Spray insecticide 10.6
6 Plug electric insecticide 8.0
7 Use temephos in water containers 10.0
8 Apply repellent 7.2
9 Install window screen 0.2
*Participants were asked about the dengue control and prevention methods that they practiced in the past month.
**Percent with at least one correct response.
doi:10.1371/journal.pntd.0002427.t003
Table 4. Attitude toward dengue prevention and vaccination (% of total responses).
Question
Strongly
disagree Disagree No opinion Agree
Strongly
Agree
Attitude on dengue prevention Your neighborhood is a dengue high-risk area (n = 499) 4.2 66.9 3.0 24.8 1.0
The city of Bandung is a dengue high-risk area (n = 498) 1.4 32.5 7.2 55.8 3.0
The government is doing their best to prevent dengue (n = 500) 0.2 16.6 3.8 73.1 6.4
You are capable of preventing dengue (n = 497) 2.0 55.7 7.4 34.2 0.6
Community members are capable of preventing dengue (n = 500) 0.8 59.0 9.8 29.6 0.8
Attitude on vaccination practice Vaccination is important for disease prevention (n = 500) 0.0 0.0 1.0 73.0 26.0
Vaccines are safe (n = 500) 0.0 2.8 3.8 85.2 8.2
You always meet your children’s vaccination schedule (n = 499) 0.0 3.8 0.2 83.6 12.4
doi:10.1371/journal.pntd.0002427.t004
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dengue as the most important (Figure 1). This is followed by
affordability (36.3%) and safety (26.3%) in the second place
whereas the number of doses required for a complete vaccination
did not seem to be of great importance relative to the
aforementioned factors.
Personal experience with dengue seems to be the only important
factor driving non-acceptance in our study. Among those who
refused to vaccinate their children, 51.7% had prior experience
with dengue, as opposed to 70.9% in the other group (x2 = 4.8, p-
value = 0.03). The statistical significance is, however, reduced
when other covariates are included in a logistic model (OR: 2.2,
95% CI: 0.978–5.095, p-value = 0.07).
Willingness to Pay for a Pediatric Dengue Vaccine
A very small fraction (2.0%) of the participants stated that they
would not vaccinate their children even if the vaccine was
provided for free, where 3.4% stated that they would vaccinate
their children only if the vaccine was provided for free. Among the
94.6% of those willing to pay for the vaccine, a J-shaped
distribution of maximum WTP was observed where 37.2% of
participants expressed their WTP below $1.1, declining to 1.8% as
price went up to a maximum of $8.25 before increasing again to
8.2% and 11.6% for maximum vaccine prices of $11.1 and higher
than $11.1, respectively (Figure 2).
We included 438 complete observations in the WTP model and
estimated conditional mean and median WTP of $2.64 and $1.94,
respectively, for a 42.6 year-old female participant with baseline
values of other covariates. The effect of covariates on dengue
vaccine WTP in general agreed with our expectation that an
increase in educational attainment, socioeconomic status, knowl-
edge, and support for vaccination increases WTP. On the
contrary, older participants were willing to pay less compared to
their younger counterparts. However, supportive attitude on
dengue prevention and higher efforts of dengue prevention were
Table 5. Proportional odds ordinal regression results associated with pediatric dengue vaccine acceptance.
Independent variables n Unlikely Undecided Likely Very likely OR (n=464) 95% CI p-value
Dengue experience 500
No 5 (3.3) 9 (5.9) 109 (72.2) 28 (18.5) - -
Yes 4 (1.2) 11 (3.2) 223 (63.9) 111 (31.8) 1.9 1.18–2.99 ,0.01
Sex 500
Female 0 (0.0) 3 (3.9) 54 (70.1) 20 (25.9) -
Male 9 (2.1) 17 (4.0) 278 (65.7) 119 (28.1) 1.0 0.59–1.85 0.89
Education level 500
Junior high and lower 4 (1.8) 9 (3.9) 150 (65.5) 66 (28.8) - - -
Senior high 5 (2.6) 10 (5.2) 134 (70.2) 42 (22.0) 0.5 0.27–0.76 ,0.01
College and higher 0 (0.0) 1 (1.3) 48 (60.0) 31 (38.8) 1.0 0.53–2.01 0.93
Socioeconomic level 491
Poorest quintile 2 (2.0) 5 (5.1) 68 (70.1) 22 (22.7) - - -
2nd 6 (6.2) 4 (4.1) 69 (68.3) 22 (21.8) 0.8 0.43–1.56 0.55
3rd 1 (1.0) 5 (5.0) 59 (62.8) 29 (30.9) 1.4 0.69–2.65 0.38
4th 0 (0.0) 2 (2.0) 67 (66.3) 32 (31.7) 1.5 0.73–2.65 0.28
Richest quintile 0 (0.0) 4 (4.3) 64 (65.9) 29 (29.9) 1.4 0.68–3.05 0.34
Dengue knowledge 479
Poor 2 (1.3) 8 (5.0) 111 (69.4) 39 (24.4) - - -
Sufficient 4 (2.4) 9 (5.4) 110 (65.5) 45 (26.8) 1.0 0.60–1.68 0.98
Good 3 (2.0) 3 (2.0) 99 (65.6) 46 (30.5) 1.3 0.74–2.28 0.35
Dengue attitude 494
Weakest 4 (3.6) 5 (4.6) 75 (68.2) 26 (23.6) - - -
Middle 4 (1.8) 9 (4.0) 139 (62.3) 71 (31.8) 1.7 1.03–2.95 0.04
Strongest 1 (0.6) 6 (3.7) 114 (70.8) 40 (24.8) 1.4 0.78–2.38 0.28
Vaccine attitude 499
Low support 2 (4.2) 3 (6.3) 37 (77.1) 6 (12.5) - - -
Supportive 6 (1.9) 12 (3.9) 220 (71.2) 71 (23.0) 2.0 0.94–4.15 0.07
Highly supportive 1 (0.7) 5 (3.5) 74 (52.1) 62 (43.7) 5.0 2.23–11.20 ,0.01
Preventive effort 500
No effort 0 (0.0) 7 (6.5) 73 (67.6) 28 (25.9) - - -
Low effort 5 (3.0) 5 (3.0) 110 (66.7) 45 (27.3) 1.0 0.57–1.72 0.97
High effort 4 (1.8) 8 (3.5) 149 (65.6) 66 (29.1) 0.9 0.52–1.51 0.66
Age (mean) 41.2 39.8 42.3 44.0 1.0 0.99–1.03 0.21
doi:10.1371/journal.pntd.0002427.t005
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found to be associated with a decrease in WTP (Table 6).
Substituting highest covariates values in the model (retaining age
at 42.6 years), our model return a maximum predicted conditional
mean and median WTP of $13.60 and $9.99, respectively.
Potential Behavior Change
Participants were asked if they would give up current dengue
prevention efforts or felt that 3M movement would no longer be
necessary, should there be a mass dengue vaccination campaign.
Figure 1. Relative importance of different vaccine characteristics. Participants were asked to rank four characteristics of vaccine according to
their relative importance. A majority of participants viewed protection against dengue to be the most important characteristic for future dengue
vaccine.
doi:10.1371/journal.pntd.0002427.g001
Figure 2. Stated WTP for a hypothetical pediatric dengue vaccine. Bars represent the interval within which the maximum WTP is contained;
solid line represents cumulative proportion of participant whose WTP lies below the upper limit of a certain interval. When the vaccine was offered
for free, 96.6% of participants (dotted line) were willing to vaccinate their children.
doi:10.1371/journal.pntd.0002427.g002
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Most participants disagreed that dengue prevention efforts were
no longer necessary. There were, however, 7.0% who thought that
3M movement would no longer be necessary, and 6.8% who
expressed that they would not practice dengue prevention
anymore. Of these, about 30% reported that they did not practice
any dengue prevention in the past month.
Discussion
Our study sought to explore public acceptance of a hypothetical
dengue vaccine, to determine whether participants would be
willing to pay for the vaccine and to explore the possibility of
behavioral changes following a dengue vaccination program. Our
results demonstrated that the hypothetical pediatric dengue
vaccine would be accepted by 94.2% of the survey participants.
Furthermore, 94.6% expressed their willingness to pay for the
vaccine with a median of stated WTP of US$1.94. We also found
that 7% of the participants agreed that other dengue prevention
methods are no longer necessary once dengue vaccine is available,
among which, 30% were not practicing any dengue prevention in
the week prior to the survey.
Acceptance of Future Dengue Vaccine
In this study, we identified the most important determinant of
public acceptance of a future dengue vaccine to be parental
acceptance of vaccination practice. The supportive attitude on
vaccination practice is reflected in national coverage of EPI
vaccination of 93.4% among infants and 92.5% among school
children, despite lower coverage in some of the eastern parts of
Indonesia where health services are less adequate [3]. Likewise,
EPI vaccines coverage in Bandung is generally above 95%, with
an exception of at birth dose of Hepatitis B vaccine (80.2%
coverage) [24]. Arguably, parents living in Bandung are used to
the idea of child vaccination due to the extensive vaccination
campaigns performed by the government and by the routine
vaccination that their children received.
Participants who had personal experience with dengue were
also more likely to accept future dengue vaccination (OR: 1.9,
95% CI: 1.18–2.99, p-value = 0.01). This makes sense because
these parents were more able to weigh the possible benefits of
vaccinating against dengue, given the perceived risk of having
their children getting the disease. Similar association was also
presented in at least one previous study showing that parents with
previous abnormal cervical smear findings were more willing to
vaccinate their daughters with HPV vaccine [32]. The same study
also found that in the presence of negative personal experience,
increasing knowledge about HPV did not have a discernible effect
in increasing parental acceptance for HPV vaccination, a result
that also comes up in our study.
Alternatively, this high acceptance can be attributed to the
perceived barrier to performing dengue prevention. As we have
shown, even though more than 90% of participants thought that
Table 6. Factors associated with willingness to pay for a pediatric dengue vaccine.
Parameter
Regression Parameter Estimate
(n=438) 95% CI Mean US$ Estimate 95% CI of US$ Estimate p-value
Intercept 9.8153 9.4128–10.2177 2.64 1.77–3.95 ,0.01
Knows someone who had dengue 0.1298 20.0486–0.3083 +0.37 20.13–0.95 0.15
Male 0.0375 20.1917–0.2668 +0.10 20.46–0.81 0.75
Age (mean centered) 20.0148 20.0222–(20.0075) 20.04 20.06–(20.02) ,0.01
Education level
Senior high school 0.1047 20.0973–0.3067 +0.29 20.25–0.95 0.31
College and higher 0.3470 0.0733–0.6208 +1.10 0.20–2.28 0.01
Socioeconomic level quintile
2nd 0.2471 0.0001–0.4940 +0.74 0.00–1.69 0.05
3rd 0.4086 0.1435–0.6736 +1.33 0.41–2.54 ,0.01
4th 0.5635 0.2800–0.8470 +2.00 0.85–3.52 ,0.01
Highest 0.7146 0.4183–1.0109 +2.76 1.37–4.62 ,0.01
Dengue knowledge category
Middle 20.0071 20.2068–0.1926 20.02 20.49–0.56 0.94
Highest 0.2272 0.0044–0.4499 +0.67 0.01–1.50 0.05
Support on dengue prevention
Supportive 20.0818 20.2897–0.1262 20.21 20.67–0.36 0.44
Highly supportive 20.0591 20.2775–0.1592 20.15 20.64–0.46 0.60
Support on vaccination
Supportive 0.2205 20.0570–0.4981 +0.65 20.15–1.71 0.12
Highly supportive 0.1819 20.1191–0.4829 +0.53 20.30–1.64 0.24
Preventive effort
Low effort 20.0062 20.2257–0.2133 20.02 20.53–0.63 0.96
Highs effort 20.0381 20.2478–0.1716 20.10 20.58–0.49 0.72
Scale 0.7863 0.7234–0.8548
doi:10.1371/journal.pntd.0002427.t006
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prevention of dengue was important, only one-third thought that
the efforts could be done by individuals or community members.
Apparently, Indonesian policy makers also have similar concern
that community-based dengue prevention will not work due to
competing priorities among the community members themselves
[9].
It is very likely that the perceived need for a dengue vaccine will
be high. This is arguably conditioned by the high incidence of
dengue in the study area and, a high community and media
attention to dengue (for example [33]). Thus, dengue has been a
constant public concern and a future vaccine is likely to be on a
high demand among the population. As was shown in this study,
the protective effect of the vaccine was highly valued by the
participants.
WTP for a Dengue Vaccine
For an average individual in our sample, the mean and the
median reported WTP for a dengue vaccine was $2.64 and $1.94,
respectively. Median WTP is considered more robust to skewness
in WTP distribution and hence will be used as the reference
measure. Although the stated public WTP seems to be low
(average household monthly expenditure in Bandung approxi-
mately US$ 200), it agrees with Indonesian policy maker’s WTP
for such vaccine, which ranged from US$0.5 per dose to US$2.0–
3.0 per series [9]. In addition, the result is not surprising
considering that all EPI vaccines can be obtained free from public
hospitals, community health centers and integrated health posts.
Production price of a dengue vaccine has been estimated to be as
low as $0.2 per dose [34]. Nonetheless, past experience have
shown new vaccines introduced at prices unaffordable to
developing countries and that creating sufficient demand to bring
the production cost down to an affordable level required
substantial efforts and time. In the case of Hepatitis B vaccine, it
took 20 years to bring the price down from $30 per dose to
approximately $1 per dose, after which its adoption and coverage
in developing countries increased significantly [35].
On the other hand, we found a wide range of prices, with a J-
shaped distribution, at which the participant would agree to pay
for the hypothetical vaccine. With almost 20% of participants
expressed their WTP for a pediatric dengue vaccine of $11.0 or
more, there could be a market for the vaccine at a higher price. It
is, however, impossible to tell how much coverage can be attained
through private sector until the vaccine is actually available in the
market. Yet, achieving a high coverage in the private sector seems
unlikely due to the fact that 45% of Indonesia’s population is not
covered by any health insurance. Social insurance schemes that
cover most of the insured do not usually cover vaccination services
either. Because vaccination services in the private market most
likely will be obtained through out-of-pocket payment, it is very
likely that provision of partially or fully subsidized vaccines will be
necessary to achieve large scale coverage.
Our study suggests that wealthier people are more likely to
spend more money for the vaccine. Hence, any pricing policy must
take into account the possibility of increasing the gap of dengue
disease burden between the affluent and the less affluent. In this
regard, price tiering and cross-subsidization of vaccine seems to be
one financing option. Another option is to advocate the inclusion
of vaccination services, or at least dengue vaccination, in the
benefit package of the upcoming universal insurance coverage
scheme that will be rolled out in the year 2014.
Potential Behavior Change
Behavior change is often cited as a concern in vaccine studies
[20,36]. In the context of the city of Bandung, an urban area that
is also known to be endemic of Chikungunya virus, vector control
is necessary even when herd immunity against dengue is achieved.
Our study found that about 7% of participants thought that the
3M movement, Indonesia’s government current mainstay of
dengue prevention, is no longer necessary when a vaccination
program is in place. This potential reduction may not have a
significant effect on the transmission of other mosquito-borne
infectious agents and hence we will interpret this number with
caution.
It is known that different types of water containers vary in their
capacity to produce adult Aedes mosquito [37,38]. However,
container productivity characteristics can differ by regions and
hence the impact of source reduction may depend on the
identification of these containers. For example, discarded items
were found to be the most productive sources of Aedes in the city of
Gioania, Brazil, whereas in Yogyakarta, Indonesia, the most
productive containers were bak mandi, large containers commonly
used to store water for bathing [39,40]. But even when source
control is applied using this information, unintended dispersion of
oviposition place to previously unrecognized containers may occur
[41].
Hence, reduction in vector control efforts may or may not
produce actual increase in vector population, especially when the
reduction is small. Nonetheless, the impact of current vector
control strategies on vector population and disease dynamics in
Indonesia is understudied and our findings may warrant further
attention to the potential effect of vector control reduction.
Study Limitations
Arguably, it remains unclear whether our findings will translate
into actual behavior. Critics argue that stated preference model
may suffer from inaccuracy and bias [42]. One important
limitation in this study is the portrayal of the hypothetical vaccine
as fully efficacious and safe, which would have affected how the
participants responded to questions related to the vaccine. This
vaccine portrayal might be elusive as was shown from recent
evidence from a phase IIb randomize trial in Thailand, in which
the tetravalent pediatric dengue vaccine provided an overall
efficacy of 30% [43]. Therefore, actual acceptance and WTP for
the vaccine could be adjusted by the actual vaccine efficacy.
However, our vaccine representation could be regarded as a way
to elicit the ceiling for acceptance and WTP such that the actual
acceptance and WTP would not exceed what we found from this
study. Lastly, our study was conducted only in one city, Bandung,
which will not represent the diversity of Indonesia as a whole.
Nonetheless, dengue has been recognized as a problem most
prominent in urban areas and therefore we believe that Bandung
can represent most, if not all, cities in Indonesia where dengue is
prominent. The study generated a wealth of information regarding
community members’ acceptance of a pediatric dengue vaccine in
Bandung, and our results can be used as the basis for further
research. We specifically propose to validate these findings in a
future community pilot, once a dengue vaccine is available.
Results from such studies can be used to further model the impact
of a dengue vaccination program and will be most useful in
assisting policy making.
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